trial · primary record
Guselkumab Subcutaneous
Colitis, Ulcerative
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 112 |
| Primary completion | 2027-04-28 |
| Primary endpoint | Percentage of Participants with Clinical Remission at Week 56 |
| Registry ID | NCT06260163 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:50.813Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06260163
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.